RxDoctor Payments Data

Thomas Doohan

Emergency Medicine · Waxhaw, NCNPI 1700811858

Payments from drug & device makers

$803in general payments, 2019–2025

Across 42 payments — averaging $19.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$262
  • Corium, LLC$156
  • Lilly USA, LLC$103
  • Johnson & Johnson$101
  • Eisai Inc.$89
  • Lundbeck LLC$55
  • plus $37 from 1 others

What the payments were for

  • Food & beverage$803100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$803 in reported general payments places this provider in the 90th percentile of 1,657 emergency medicine providers in North Carolina.

See all emergency medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$71,124
Medicare patients
275
Services billed
9,435

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
DescovyEmtricitabine/Tenofov Alafenam11$23,592
Memantine Hcl631$17,961
Rivastigmine55$7,107
AdlarityDonepezil Hcl12$5,226
Donepezil Hcl462$3,846
RivastigmineRivastigmine Tartrate75$3,734
Divalproex Sodium127$2,224
Galantamine ErGalantamine Hbr23$1,877
Mirtazapine73$1,243
Buspirone Hcl88$946
Quetiapine Fumarate59$814
Memantine Hcl ErMemantine Hcl12$805
Divalproex Sodium ErDivalproex Sodium43$696
Sertraline Hcl68$489
Olanzapine42$416

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Corium, LLCAdlarity$156$5,22612 claims
Lilly USA, LLCOlanzapine$103$41642 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,657 emergency medicine providers in North Carolina.

Other emergency medicine in Waxhaw

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →